About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSeattle/Pacific Northwest
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,410
By Phase
PHASE1: 4PHASE4: 1PHASE2: 2PHASE2/PHASE3: 2
By Status
COMPLETED: 6TERMINATED: 2RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06432647Lead Sponsor
A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105
PHASE1Completed
80 participants
Started: Apr 24, 2024 · Completed: Nov 25, 2024
NCT05916911Collaborator
Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
PHASE4Recruiting
120 participants
Started: Jun 7, 2023 · Completed: Jan 8, 2025
NCT05511558Lead Sponsor
A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)
PHASE1Completed
8 participants
Started: Jul 13, 2022 · Completed: Oct 26, 2022
NCT05169671Lead Sponsor
Safety, Tolerability, and Pharmacokinetics Study of ATH-1020
PHASE1Completed
32 participants
Started: Mar 30, 2022 · Completed: Sep 9, 2022
NCT04831281Lead Sponsor
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)
PHASE2Terminated
28 participants
Started: Jan 20, 2022 · Completed: Apr 19, 2023
Locations (1)
Headquarters
Bothell, WA, United States
Map
Loading map...